Transcatheter edge-to-edge repair following surgical valve repair with ring implantation: Results from the multicentre "Clip-in-Ring" registry - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Archives of cardiovascular diseases Année : 2022

Transcatheter edge-to-edge repair following surgical valve repair with ring implantation: Results from the multicentre "Clip-in-Ring" registry

Guillaume Bonnet
  • Fonction : Auteur

Résumé

BACKGROUND: Management of mitral regurgitation recurrence after failed surgical valve repair with ring implantation is controversial. AIM: To describe the French experience regarding midterm safety and efficacy of transcatheter edge-to-edge mitral valve repair (TEER) in patients with failed surgical valve repair with ring implantation. METHODS: The "Clip-in-Ring" registry is a multicentre registry conducted in 11 centres in France, approved by local institutional review boards, of consecutive TEER following surgical valve repair with ring implantation. Outcomes were Mitral Valve Academic Research Consortium (MVARC) technical success, modified 30-day device and procedural success (where 10mmHg is considered as a cut-off for significant mitral stenosis) and MVARC complications. RESULTS: Twenty-three patients were studied: mean age, 69±10years; male sex, 74%; EuroSCORE II, 16±17; left ventricular ejection fraction, 53±12%; mitral regurgitation grade 3+/4+, 17%/78%; New York Heart Association class III/IV, 47%/22%; median surgery to TEER delay, 23 (6-94) months. Technical success was 100%. At discharge, residual mitral regurgitation grade was≤2+ in 87% and median transmitral gradient was 4 (3-5) mmHg. Thirty-day modified MVARC device and procedural success was 82%: four patients (17%) had residual mitral regurgitation grade>2+, including two patients who needed complementary surgery. No patient had a 30-day transmitral gradient>7mmHg. No patient died or had a stroke or any life-threatening complications. One patient presented a vascular access complication requiring transfusion. No other MVARC-2 adverse event was reported. CONCLUSIONS: TEER in patients with failed mitral ring is feasible and safe. Further studies shoulddelineate its exact role in the therapeutic armamentarium for this medical issue.
Fichier principal
Vignette du fichier
Leurent et al - 2022 - Transcatheter edge-to-edge repair following surgical valve repair.pdf (1.35 Mo) Télécharger le fichier
Leurent_ScienceDirect_files_14Feb2023_12-02-11.928.zip (1.13 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03798967 , version 1 (14-02-2023)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Guillaume Leurent, Vincent Auffret, Daniel Grinberg, Robin Le Ruz, Christophe Saint Etienne, et al.. Transcatheter edge-to-edge repair following surgical valve repair with ring implantation: Results from the multicentre "Clip-in-Ring" registry. Archives of cardiovascular diseases, 2022, 115 (10), pp.521-528. ⟨10.1016/j.acvd.2022.05.009⟩. ⟨hal-03798967⟩
56 Consultations
44 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More